When comparing different molecular biological subtypes of breast cancer, it was shown that a decrease in the level of MUC1 CA 15-3, CA 27.29, and MCA was observed only for HER2-positive subtypes (luminal B (HER2+) and non-luminal) (Figure 2). This evidence concerns the gene ERBB2 and breast cancer.